Leukocyte count predicts severity of COVID-19 symptoms in older women

Sev­er­al star­tups study­ing psy­che­delics have re­ceived de­cent cap­i­tal in­vest­ments and start­ed test­ing the ef­fi­ca­cy of their treat­ments, and now the FDA has re­leased a draft

Abi­vax start­ed trad­ing Fri­day on the Nas­daq, as the decade-old Paris-based start­up aims to raise about $236 mil­lion to get Phase III re­sults for its

Sabestomig is a monoclonal antibody commercialized by AstraZeneca, with a leading Phase II program in Non-Small Cell Lung Carcinoma.